Plantar Fascitis
Conditions
Keywords
ozone therapy, ESWT
Brief summary
Extracorporeal Shock Wave Therapy (ESWT) is a conservative treatment method that has been widely used in musculoskeletal diseases in recent years. Its mechanism is to provide hyperstimulation and vascularity increase with the help of acoustic waves focused on a specific area, thus accelerating healing and reducing pain. This method, which is frequently used in plantar fasciitis, is frequently applied to patients whose symptoms persist despite first-line treatment strategies. Ozone injections have been frequently used in musculoskeletal disorders in recent years and are mainly used in osteoarthritis, osteomyelitis, tendon, fascia and ligament injuries, vertebra and disc pathologies and neuropathic pain. Analgesic effect on musculoskeletal system (release of endorphins, activation of antinociceptive system, reduction of edema) anti-inflammatory effect (regulation of cytokine release, reduction of superoxide radicals, modulation of prostaglandin), regulation of local oxygenation and circulation, tissue repair (neutralization of preteolytic enzymes, fibroblast proliferation) and has an antimicrobial effect. Although it is also used in the treatment of plantar fasciitis, there are limited articles on this subject in the literature. In our study, it was aimed to compare the effectiveness of ESWT and ozone injection therapy, which are two treatment strategies with regenerative action mechanisms, in patients with resistant plantar fasciitis.
Interventions
DEVICEOzone Generator
Ultrasound guided ozone therapy
Extracorporeal shock wave therapy device
Sponsors
Ankara City Hospital Bilkent
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Be over 18 years old * Heel pain lasting longer than 3 months * Localized pain and tenderness on palpation on the medial aspect of the calcaneal tuberosity when the ankle is fully dorsiflexed. * In the first step of walking, \>50 mm according to VAS. and description of pain * Presence of plantar fasciitis typical findings on ultrasonography (thickening more than 4 mm in the proximal plantar fascia with changes in fibril pattern) * Failure to respond to conservative treatment before (nonsteroidal anti-inflammatory drugs, stretching, heel cushion, shoe modifications, orthotics, cold, heat, taping, massage)
Exclusion criteria
* being under the age of 18 * Any skin lesions in the heel area * Inflammatory, rheumatic arthritis * Having a history of fracture, trauma or operation in the heel area * Systemic infection or malignancy * Having a pacemaker * Local injection to the heel area in the last 6 months or use of topical or oral nonsteroidal anti-inflammatory drugs in the last 2 weeks
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analog Scale | pre-treatment, immediately post-treatment and three months follow-up | measurement for pain severity, It is a value between 0-100. 0 means no pain and 100 means maximum pain. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| plantar fascia thickness | pre-treatment, immediately post-treatment and three months follow-up | sonographic measurement for plantar fascia |
| Foot Function İndex | pre-treatment, immediately post-treatment and three months follow-up | measurements for foot function. An increase in the value indicates worse foot functions. |
Countries
Turkey (Türkiye)
Contacts
Primary ContactBerke Aras, Ass. Professor
Outcome results
None listed